Why is P & G Health Ltd falling/rising?

As of 12-Aug, Procter & Gamble Health Ltd is experiencing a price increase, currently at 6,353.00, reflecting a rise of 43.0 points or 0.68%. The stock is trading close to its 52-week high, just 2.16% away from Rs 6,490, and has outperformed its sector by 0.3% today. Over the past week, the stock has gained 2.71%, and it has shown strong performance over the last month with a return of 10.11%. The company has demonstrated high management efficiency with a return on equity (ROE) of 32.32% and has maintained a low debt-to-equity ratio. Additionally, it has reported positive results for the last four consecutive quarters, contributing to its favorable market performance despite a decline in investor participation, as indicated by a significant drop in delivery volume.
In the broader market context, while the stock has generated a return of 22.07% over the past year, the benchmark Sensex has only returned 0.74%, highlighting the stock's strong performance relative to the market. The stock's liquidity remains adequate for trading, and it is currently trading above all its moving averages, indicating positive momentum. However, there are concerns regarding long-term growth, as net sales have only grown at an annual rate of 7.39% over the last five years. Despite these risks, the high institutional holdings at 21.15% suggest confidence from more knowledgeable investors, which may further support the stock's upward movement.